Article Sidebar

PDF (Tiếng Việt)
Published: 2023-01-10
Abstract Views: 166
Views PDF (Tiếng Việt): 287
DOI: https://doi.org/10.52852/tcncyh.v160i12V1.1157
Issue
Vol. 160 No. 12V1 (2022)
Section
Các bài báo
How to Cite
Nhi, T. T. D. ., & Nhung, P. H. . (2023). 4. The amikacin mic distribution of Klebsiella pneumoniae . Journal of Medical Research, 160(12V1), 26-32. https://doi.org/10.52852/tcncyh.v160i12V1.1157

4. The amikacin mic distribution of Klebsiella pneumoniae

Than Thi Dung Nhi, Pham Hong Nhung

Main Article Content

Abstract

Amikacin MIC value of 247 Klebsiella pneumoniae strains isolated from the ICU, Bach Mai Hospital in 2019 - 2021 were determinedby a broth microdilution method. The sensitivity to various antibiotics was also determined according to the amikacin MIC distribution of the bacteria. The result showed that the susceptibility rate of Klebsiella pneumoniae to amikacin was relatively high (76.9%). The distribution of bacteria according to the amikacin MIC was not uniform, in which strains with MIC from 1 - 4 µg/mL represented 55.9% and strains with MIC equal to 2 were most prevalent. Bacteria with MIC ≤ 8 µg/mL accounted for 65.6% and they were relatively sensitive to fosfomycin (80%), gentamicin (63%), and carbapenem (about 50%). Strains with amikacin MIC from 16 - 32 µg/mL (14.5%) were less susceptible to the aforementioned antibiotics by 60%, 25%, and 5.6%, respectively. With group resistant to amikacin with MIC > 32 µg/mL, the sensitivity to all tested antibiotics was less than 30%.

Article Details

Keywords

Klebsiella pneumoniae, amikacin, MIC

References

1. Phu VD, Nadjm B, Duy NHA, et al. Ventilator-associated respiratory infection in a resource-restricted setting: Impact and etiology. J Intensive Care. 2017;5:69. doi: 10.1186/s40560-017-0266-4.
2. Dat VQ, Vu HN, Nguyen The H, et al. Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam: Aetiology, drug resistance, and treatment outcome. BMC Infect Dis. 2017;17(1):493. doi: 10.1186/s12879-017-2582-7.
3. Phạm Hồng Nhung. Báo cáo số liệu năm 2018 tại Khoa HSTC bệnh viện Bạch mai. Cảnh giác dược online. 2019.
4. Brink AJ. Epidemiology of carbapenem-resistant Gram-negative infections globally. Curr Opin Infect Dis. 2019;32(6):609-616. doi: 10.1097/QCO.0000000000000608.
5. Zavascki AP, Klee BO, Bulitta JB. Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility. Expert Rev Anti Infect Ther. 2017;15(6):519-526. doi: 10.1080/14787210.2017.1316193.
6. Patel JB. Cockerill FR. Bradford PA, et al. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard - Tenth Edition. 2015
7. Ii JSL, Weinstein MP, Bobenchik AM, et al. Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. 2020. https://clsi.org/media/3481/m100ed30_sample.pdf.
8. Patel JB. Cockerill FR. Bradford PA, et al. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard. Twelfth Edition. 2015.
9. EUCAST. Clinical breakpoints and dosing of antibiotics. 2022
10. K J Shaw, P N Rather, R S Hare, and G H Miller. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. - PMC. Accessed August 31, 2022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC372903/
11. Nguyễn Hoàng Anh. Phân tích dược động học quần thể và mô phỏng PK/PD của amikacin ở bệnh nhân nặng điều trị tại khoa Hồi sức tích cực - Bệnh viện Bạch Mai. Cảnh giác dược online. 2022:21.